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Abstract 
Background: Admixture analysis of age at onset (AAO) has helped delineating the clinical profile of early onset (EO) 
bipolar disorder (BD). However, there is scarce evidence comparing the distributional properties of AAO as well as the 
clinical features of EO BD type 1 (BD1) with EO BD type 2 (BD2). To this end, we studied 515 BD patients (224 BD1, 279 
BD2, and 12 BD not otherwise specified [NOS]) diagnosed according to DSM-IV-TR criteria.
Methods: AAO was defined as the first reliably diagnosed hypo/manic or depressive episode according to diagnos-
tic criteria. We used normal distribution mixture analysis to identify subgroups of patients according to AAO. Models 
were chosen according to the Schwarz’s Bayesian information criteria (BIC). Clinical correlates of EO were analysed 
using univariate tests and multivariate logistic regression models.
Results: A two normal components model best fitted the observed distribution of AAO in BD1 (BIC = −1599.3), BD2 
(BIC = −2158.4), and in the whole sample (BIC = −3854.9). A higher number of EO BD2 patients had a depression-
(hypo)mania-free interval (DMI) course, while a higher rate of (hypo)mania-depression-free interval (MDI) course was 
found in EO BD1. EO BD2 had also a higher rate of comorbidity with alcohol dependence compared to EO BD1. The 
latter finding was confirmed by multivariate logistic regression analysis.
Conclusions: In conclusion, both BD1 and BD2 had bimodal AAO distributions, but EO subgroups had a diagnostic-
specific clinical delineation.
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Background
Bipolar disorder (BD) is a heritable psychiatric illness 
characterised by cyclic mood episodes of opposite polar-
ity alternating with intervals of well-being (Goodwin and 
Jamison 2007). As in other psychiatric complex genetic 
diseases, the relatively high clinical heterogeneity of BD 
might have hindered the identification of molecular and 
clinical determinants of risk as well as of predictors of 
treatment outcome (Alda 2004). The magnitude of clinical 
heterogeneity might be reduced by studying subgroups of 
BD patients sharing specific clinical characteristics such 
as patterns of treatment response (Alda et al. 2005), mood 
incongruent psychosis (Goes et al. 2007), or early illness 
onset (Jamain et al. 2014). Indeed, the extensive analysis 
of age at onset (AAO) BD subgroups through admixture 
analysis has shown clinical (Bellivier et al. 2001; Lin et al. 
2005; Manchia et  al. 2008; Tozzi et  al. 2011; Ortiz et  al. 
2011) and genetic (Etain et al. 2006; Severino et al. 2009; 
Etain et al. 2010; Belmonte et al. 2011) characteristics spe-
cific, particularly, to early onset (EO) BD.
As the vast majority of studies investigated BD type 
1 (BD1) samples, it remains to be established, however, 
whether this clinical delineation of EO is present also in 
BD type 2 (BD2) patients. Furthermore, the distributional 
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properties of AAO have never been investigated in sam-
ples exclusively composed of BD2 patients.
Methods
Aims
The primary aim of the present study was to test whether 
BD1 and BD2 differed in terms of AAO distributions. 
The secondary objective was to test whether EO had clin-
ical characteristics specific for each diagnostic subgroup. 
To this end, we (i) studied the AAO distribution of each 
diagnostic subgroup with mixture modelling; (ii) com-
pared the AAO distributions identified in BD1 and BD2; 
(iii) analyzed the pattern of associations of a set of demo-
graphic and clinical variables with EO in each diagnostic 
subgroup; and (iv) compared the clinical association pat-
terns between EO BD1 and EO BD2.
Patient population and assessment instruments
Our sample consisted of 515 unrelated patients with 
BD. Two hundred and twenty-four were diagnosed with 
BD1, while 279 had a diagnosis of BD2, and 12 had a 
diagnosis BD not otherwise specified (NOS). All sub-
jects were of Italian ancestry. Patients were recruited 
at the Anxiety and Mood Disorders Unit, University 
of Turin, Italy and at the Department of Psychiatry, 
University of Naples SUN, Napoli, Italy. Certified psy-
chiatrists with at least 4  years of postgraduate clini-
cal experience performed the clinical assessment of 
patients. All potential interviewers met prior to study 
beginning and underwent a common extensive training 
prior to conducting the assessments. They were trained 
in the use of a common semi-structured interview that 
was used to collect (a) socio-demographic data (age, 
gender, marital status, years of education, and occupa-
tional status); (b) diagnosis (current and lifetime), which 
were performed according to the Diagnostic and Statis-
tical Manual of Mental Disorders (DSM)-IV-Text Revi-
sion (TR) criteria (American Psychiatric Association 
2000) using the structured clinical interview for DSM-
IV-TR Axis I disorders (SCID-I/P) (First et al. 2002); (c) 
clinical data including AAO. In addition, a systematic 
review of patients’ medical records helped clinicians to 
establish AAO and corroborate data concerning clini-
cal characteristics of the disorder emerging from direct 
interview. Age at onset was defined as the first reliably 
diagnosed hypo/manic or depressive episode meeting 
the diagnostic criteria. External corroboration for AAO 
was obtained, whenever possible, by directly interview-
ing, with patient’s consent, a first-degree family mem-
ber or other significant individuals. For the purposes of 
the present study, we included only subjects for whom 
it was possible to establish AAO with complete agree-
ment between the information provided by patients and 
their relatives. Age at interview was defined as the age 
at which subjects were first assessed by a clinician at 
each research centre.
In the early phase of the study, inter-rater reliability 
of the diagnosis of Axis I disorders with the SCID-I was 
ascertained. The inter-rater reliability was found to be 
good: Cohen kappa coefficient was 0.89 for the presence 
of any current or lifetime Axis I disorder.
Data analysis
We used Gaussian distribution mixture analysis to test 
whether we could identify subgroups of patients accord-
ing to the AAO. We investigated a range of number of 
AAO groups (1–9). The choice of the mixture model 
that best fit the distribution of AAO was made accord-
ing to the Schwarz’s Bayesian information criteria (BIC). 
Specifically, the analysis performed with the “Mclust” 
(Fraley and Raftery 1999; Fraley et  al. 2014) package 
implemented in R (R Development Core Team 2008) 
indicates the best model as the one with the highest 
BIC among the fitted models (Fraley and Raftery 2007). 
This package estimates parameters of the model using 
an expectation–maximization (EM) algorithm. Cut-off 
points were derived using the Gaussian cumulative distri-
bution function of estimated AAO mixture function and 
calculating each data point’s probability of belonging to 
each class. Specifically, once the mixture model param-
eters were estimated, we calculated the posterior prob-
ability of any data point. The resulting probabilities were 
then compared in order to establish which class the data 
point belonged to. Gaussian mixture analysis (both num-
ber of components and parameters estimates) was also 
replicated and confirmed with the “Mixtools” R package 
(Benaglia et  al. 2009). We used Kolmogorov–Smirnov 
(K–S) test to determine whether the Gaussian cumulative 
distribution function of estimated AAO mixture identi-
fied in BD1 patients was significantly different from the 
one identified in BD2 patients. Further, we used K–S to 
test for differences in the AAO Gaussian cumulative dis-
tribution function of estimated AAO mixture between 
participating research centres. We tested the associa-
tion of continuous and categorical clinical variables with 
AAO subgroups using univariate analysis (t test or χ2 
test as appropriate). The independent variables tested 
included sex, age at interview, diagnosis, illness duration, 
presence of family history of any DSM-IV-TR psychiatric 
disorder, presence of family history of BD and any DSM-
IV-TR mood disorders, number of manic/hypomanic, 
depressive and mixed episodes, type of clinical course 
cycle [i.e. (hypo)mania-depression-free interval (MDI), 
depression-(hypo)mania-free interval (DMI), irregu-
lar cycling, continuous cycling, rapid cycling], presence 
of lifetime suicidal behaviour, lifetime comorbidity with 
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substance (other than alcohol) dependence, and lifetime 
comorbidity with drug and/or alcohol dependence. Sta-
tistical significance was set at α = 0.05. Only clinical vari-
ables presenting a statistical significant association with 
an AAO subgroup (p  <  0.05) of each diagnostic sample 
(BD1 and BD2) were entered into a backward stepwise 
multivariate binary logistic model to account for possible 
intercorrelations. All statistical analyses, except for mix-
ture modelling, were performed with STATA/SE 12.0.
Results
Age at onset distribution: Gaussian mixture analysis
The BD1 sample (99 males and 125 females) had a mean 
age at interview (±SD) of 47.2 years (±13.0) and a mean 
AAO of 26.7  years (±9.2). A two normal components 
model best fitted the observed distribution of AAO 
(BIC  =  −1599.3) (Fig.  1). Models with three and four 
components did not improve the fit (Table 1).
The EO component had a mean AAO of 22.6  years 
(±4.8), while the late onset (LO) component had a mean 
AAO of 35.1  years (±10.1) comprising 67% and 33% of 
the population proportion, respectively. The cut-off point, 
derived by the Gaussian cumulative distribution function 
of the latter estimated AAO function, was at 32 years for 
BD1 (EO group <32 years; LO group ≥32 years) with 169 
patients in the EO group and 55 in the LO group.
The BD2 sample (114 males and 165 females) had a 
mean age at interview of 50.6 years (±14.8) and a mean 
AAO of 30.6 years (±12.7). The observed distribution of 
AAO was also best fitted by a two normal components 
model (BIC = −2158.4) (Fig. 2).
No improvement of the fit was observed with three and 
four components models (Table 1). The BD2 sample had 
an EO component with mean AAO of 20.9 years (±4.1) 
and a LO component with mean AAO of 38.2  years 
(±11.8) with population proportions of 44% and 56%, 
respectively. The cut-off point, derived by the Gauss-
ian cumulative distribution function of this estimated 
AAO function, was at 28 years (EO group <28 years; LO 
group ≥28 years). The EO group comprised 142 patients, 
while the LO group included 137 patients.
Kolmogorov–Smirnov test showed that the Gauss-
ian cumulative distribution functions of estimated AAO 
mixture of BD1 and BD2 differed significantly (D = 0.18, 
p < 0.00001) (Fig. 3). Conversely, there was no significant 
difference between the Gaussian cumulative distributions 
Fig. 1 Age at onset distribution in bipolar disorder type 1 patients 
(N = 224). Gaussian probability density function was derived by the 
estimated age at onset mixture function in bipolar disorder type 1 
patients
Table 1 Age at  onset distributions identified by  Gauss-
ian mixture analysis in bipolar disorder type 1 and type 2 
and in the whole sample
Best fitting mixture models are typed in italics
M model, BIC Bayesian information criteria, SD standard deviation
Mixture 
model
BIC Model compo-
nents
Mean SD Proportion 
(%)
Bipolar disorder type 1 sample (n = 224)
 M1 −1637.7 1st component 26.7 9.1 100.0
 M2 −1599.4 1st component 22.6 4.8 66.9
2nd component 35.1 10.1 33.1
 M3 −1611.0 1st component 18.7 3.0 27.1
2nd component 25.6 4.4 45.7
3rd component 36.6 10.1 27.2
 M4 −1624.0 1st component 17.9 2.6 23.1
2nd component 23.8 3.1 28.2
3rd component 28.8 5.9 33.4
4th component 40.9 9.9 15.3 
Bipolar disorder type 2 sample (n = 279)
 M1 −2218.4 1st component 30.6 12.6 100.0
 M2 −2158.4 1st component 20.9 4.1 44.0
2nd component 38.2 11.8 56.0
 M3 −2163.2 1st component 19.3 3.3 33.1
2nd component 28.4 6.1 33.7
3rd component 44.0 11.0 33.2
 M4 −2177.7 1st component 17.6 2.5 22.8
2nd component 23.0 2.8 24.7
3rd component 32.2 4.4 22.7
4th component 45.6 10.3 29.8
Total bipolar disorder sample (n = 515)
 M1 −3986.7 1st component 29.0 11.5 100.0
 M2 −3854.9 1st component 21.9 4.6 55.0
2nd component 37.6 11.5 45.0
 M3 −3856.0 1st component 19.2 3.2 28.9
2nd component 26.5 5.6 40.6
3rd component 41.5 11.2 30.6
 M4 −3868.3 1st component 17.8 2.6 22.8
2nd component 23.3 3.1 28.0
3rd component 31.1 5.1 24.0
4th component 43.4 10.9 25.2
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of estimated AAO mixture of the two participating 
research centres (D  =  0.05, p  =  0.57). Finally, Gaussian 
mixture analysis confirmed a best fitting model of two nor-
mal components (detailed in Table 1) in the whole sample 
of 515 BD patients (216 males and 299 females), which 
included 12 subjects with BD NOS (Fig.  4). The cut-off 
point, derived by the Gaussian cumulative distribution 
function of this estimated AAO function, was at 30 years.
Clinical correlates of early onset: patterns of association 
in bipolar disorder type 1 and type 2 diagnostic subgroups
As shown in Table 2, a trend association (p = 0.05) was 
identified for the presence of family history of any DSM-
IV-TR mood disorder, with LO BD1 having a higher rate 
than EO BD1. Early onset BD1 had a lower age at inter-
view and a longer duration of illness than LO BD1.
Early onset BD2 had a higher rate of comorbidity with 
alcohol dependence, as well as a higher rate of family his-
tory of BD in EO BD2 compared to LO BD2 (Table  2). 
Further, they also had a lower age at interview and longer 
illness duration than LO BD2.
We then performed a multivariate logistic regres-
sion in BD2 confirming that family history of BD [odds 
ratio (OR)  =  1.97, 95% confidence interval (CI) 1.04–
3.73, p  =  0.04], comorbidity with alcohol dependence 
(OR = 3.2, 95% CI 1.21–8.54, p = 0.02), and illness dura-
tion (OR =  1.03, 95% CI 1.008–1.048, p =  0.006) were 
associated with EO. As age at interview was used to cal-
culate illness duration, and consequently significantly 
correlated with it (r = −0.97), it was not included in the 
logistic regression model. Multivariate analysis was not 
performed in BD1 since no clinical variable was signifi-
cantly associated with AAO subgroup in univariate test.
Clinical correlates of early onset: comparison 
between bipolar disorder type 1 and type 2 diagnostic 
subgroups
The mean AAO was significantly lower in BD1 compared 
to BD2 (26.7 ± 9.2 vs. 30.6 ± 12.7; t = −3.8; p < 0.0001). 
The results of the univariate analysis are shown in 
Table  3. Early onset BD1 patients were older than EO 
BD2. Conversely, EO BD2 had a higher rate of comor-
bidity with alcohol dependence. In addition, a higher 
number of EO BD2 presented with a DMI course, while 
a higher rate of MDI course was found in EO BD1. The 
multivariate binary logistic regression confirmed the 
association of comorbidity with alcohol dependence with 
EO BD2 (OR = 0.4, 95% CI 0.18–0.90, p = 0.02).
Fig. 2 Age at onset distribution in bipolar disorder type 2 patients 
(N = 279). Gaussian probability density function was derived by the 
estimated age at onset mixture function in bipolar disorder type 2 
patients
Fig. 3 Kolmogorov–Smirnov test between theoretical age at onset in 
bipolar disorder type 1 and type 2 patients. Probability density func-
tions of the two estimated age at onset mixture function. BD1 bipolar 
disorder type 1, BD2 bipolar disorder type 2
Fig. 4 Age at onset distribution in the whole sample of bipolar 
disorder patients (N = 515). Gaussian probability density function was 
derived by the estimated age at onset mixture function in the whole 
sample of bipolar disorder patients
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Table 2 Comparison of clinical correlates between early and late onset bipolar disorder type 1 and type 2 patients
Clinical variable Bipolar disorder type 1 (N = 224) χ2 or t P
Early onset (N = 169) Late onset (N = 55)
Female (%) 73 (43.2) 26 (47.3) 0.3 0.6
Age at interview, mean (SD) 45.3 (13.5) 53.1 (8.8) 4.0 <0.0001
Presence of family history of any psychiatric disorder (%)a 99 (58.9) 37 (67.3) 1.2 0.3
Presence of family history of mood disorder (%)b 85 (52.5) 34 (68.0) 3.7 0.05
Presence of family history of bipolar disorder (%)c 31 (18.5) 13 (23.6) 0.7 0.4
Number of manic/hypomanic episodes, mean (SD)d 4.4 (5.1) 3.6 (3.2) −1.1 0.3
Number of depressive episodes, mean (SD)e 5.5 (4.7) 4.8 (4.4) −0.9 0.3
Number of mixed episodes, mean (SD)f 0.6 (1.6) 0.8 (1.3) 0.8 0.4
Illness duration, mean (SD) 22.5 (12.8) 13.5 (8.6) −4.9 <0.0001
Lifetime comorbidity with substance dependence (%) 15 (8.9) 4 (7.3) 0.1 0.7
Lifetime comorbidity with alcohol dependence (%) 10 (5.9) 1 (1.8) 1.5 0.2
Presence of suicidal behaviour (%) 47 (28) 11 (20) 1.4 0.2
Type of clinical course cycle
 MDI (%) 75 (44.4) 22 (40.0) 3.7 0.45
 DMI (%) 20 (11.8) 11 (20.0)
 Irregular cycling (%) 65 (38.5) 21 (38.2)
 Continuous cycling (%) 5 (3.0) 1 (1.8)
 Rapid cycling (%) 4 (2.4) 0 (0.0)
Clinical variable Bipolar disorder type 2 (N = 279) χ2 or t p
Early onset (N = 142) Late onset (N = 137)
Female (%) 85 (59.9) 80 (58.4) 0.06 0.8
Age at interview, mean (SD) 42.8 (14.4) 58.7 (10.1) 10.6 <0.0001
Presence of family history of any psychiatric disorder (%) 93 (65.5) 87 (63.5) 0.1 0.7
Presence of family history of mood disorder (%)b 84 (60.0) 79 (58.5) 0.06 0.8
Presence of family history of bipolar disorder (%) 36 (25.4) 19 (13.9) 5.8 0.02
Number of manic/hypomanic episodes, mean (SD)d 4.3 (4.2) 3.7 (4.3) −1.1 0.3
Number of depressive episodes, mean (SD)e 6.0 (5.6) 5.4 (5.3) −1.0 0.3
Illness duration, mean (SD)g 22.0 (13.7) 17.8 (11.2) −2.8 0.005
Lifetime comorbidity with substance dependence (%) 8 (5.6) 6 (4.4) 0.2 0.6
Lifetime comorbidity with alcohol dependence (%) 19 (13.4) 6 (4.4) 6.9 0.01
Presence of suicidal behaviour (%) 45 (31.7) 29 (21.2) 3.9 0.06
Type of clinical course cycle
 MDI (%) 51 (35.9) 45 (32.8) 3.9 0.4
 DMI (%) 31 (21.8) 35 (25.5)
 Irregular cycling (%) 58 (40.8) 52 (38.0)
 Continuous cycling (%) 2 (1.4) 2 (1.5)
 Rapid cycling (%) 0 (0.0) 3 (2.2)
Significant values are typed in italics
MDI (hypo)mania-depression-free interval, DMI depression-(hypo)mania-free interval, SD Standard Deviation, p p value
a  BD1: missing data for 1 patient
b  BD1: missing data for 12 patients, BD2: missing data for 4 patients
c  BD1: missing data for 1 patient
d  BD1: missing data for 1 patient, BD2: missing data for 4 patients
e  BD1: missing data for 1 patient, BD2: missing data for 4 patients
f  BD1: missing data for 1 patient, BD2: missing data for 3 patients
g  BD2: missing data for 2 patients
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Discussion
The present study highlighted that a two normal compo-
nent model in BD1 as well as in BD2 diagnostic subgroup 
best described the distribution of AAO. This finding was 
not reflected, however, in similar distributional proper-
ties of AAO, as well as in comparable pattern of associa-
tion with clinical variables between the two diagnostic 
subgroups. In fact, our study found that EO BD2 patients 
had a higher rate of alcohol dependence compared to 
both LO BD2 and EO BD1. Further, EO BD2 patients had 
more frequently a DMI type of clinical course, while the 
MDI type was more frequently associated with EO BD1. 
Finally, EO BD2 showed a higher familial load for BD 
compared to LO BD.
The bimodal AAO distribution found in both BD 
diagnostic subgroups and in the whole sample of 515 
patients is consistent with some studies (Ortiz et al. 2011; 
Kennedy et  al. 2005; Javaid et  al. 2011). Conversely, the 
majority of studies on mixture analysis of AAO showed 
a trimodal distribution in samples comprising mainly 
BD1 patients (Bellivier et al. 2001, 2003; Lin et al. 2006; 
Severino et  al. 2009; Hamshere et  al. 2009; Tozzi et  al. 
2011; Bellivier et  al. 2014; Golmard et  al. 2015). Of 
note, a recent study showed that bimodal and trimodal 
distribution fit equally well the AAO of BD (Grigoroiu-
Serbanescu et  al. 2014). Further research is needed to 
determine which distribution (bi- or tri-modal) better 
describes AAO in BD and which is (or which are) the 
best cut-off(s) before investigating clinical correlates and 
genetic differences between subgroups based on AAO. 
In fact, thresholds between subgroups found in differ-
ent studies differed [e.g. thresholds between the inter-
mediate and late AAO subgroups differed from 25 in one 
study (Tozzi et al. 2011) to 40 years in another (Hamshere 
et  al. 2009)] as well as percentages of patients in each 
AAO subgroups [e.g. percentages of patients attributed 
to the early onset subgroup varied between 21.4% (Bel-
livier et  al. 2001) and 79.7% (Lin et  al. 2006)]. Discrep-
ancies in the identified AAO distributions, cut-off points, 
and proportions of patients in each AAO subgroups 
may depend on diverse assessment methods, recall bias, 
study design (Montlahuc et  al. 2016), and differences in 
characteristics of samples studied, including geographic 
location (Post et al. 2008; Bellivier et al. 2014) and birth 
cohort (Bauer et al. 2015; Golmard et al. 2015). Concern-
ing study design, Montlahuc et al. (2016) tested whether 
cross‐sectional designs (which cause right truncation), 
unreliable diagnosis for individuals younger than 10 years 
old (which causes left truncation), and the selection cri-
terion used for admixture analysis impacted the number 
of identified AAO subgroups. Importantly, a combination 
of left and right truncation, which is common in previ-
ously published studies of AAO admixture analysis, 
appeared to significantly influence the number of AAO 
subgroups detected (Montlahuc et al. 2016). Geographi-
cal location appears also to impact on AAO admixture 
Table 3 Comparison of clinical correlates between early onset bipolar disorder type 1 and type 2 patients
Significant values are typed in italics
MDI (hypo)mania-depression-free interval, DMI depression-(hypo)mania-free interval, SD Standard Deviation, p p value
Clinical variable Early onset diagnostic subgroup χ2 or t P
Bipolar disorder type 1 (N = 169) Bipolar disorder type 2 (N = 142)
Female (%) 96 (56.8) 85 (59.9) 0.3 0.6
Age at interview, mean (SD) 45.3 (13.5) 42.8 (14.4) 1.5 0.01
Presence of family history of any psychiatric disorder (%) 99 (58.9) 93 (65.5) 1.4 0.2
Presence of family history of mood disorder (%) 85 (52.5) 84 (60.0) 1.7 0.2
Presence of family history of bipolar disorder (%) 31 (18.5) 36 (25.4) 2.2 0.1
Number of manic/hypomanic episodes, mean (SD) 4.4 (5.1) 4.3 (4.2) 0.2 0.8
Number of depressive episodes, mean (SD) 5.5 (4.7) 6.0 (5.6) −0.8 0.4
Illness duration, mean (SD) 22.5 (12.8) 21.9 (13.7) 0.4 0.7
Lifetime comorbidity with substance dependence (%) 15 (8.9) 8 (5.6) 1.2 0.3
Lifetime comorbidity with alcohol dependence (%) 10 (5.9) 19 (13.4) 5.1 0.02
Presence of suicidal behaviour (%) 47 (28.0) 45 (31.7) 0.5 0.5
Type of clinical course cycle
 MDI (%) 75 (44.4) 51 (35.9) 10.4 0.035
 DMI (%) 20 (11.8) 31 (21.8)
 Irregular cycling (%) 65 (38.5) 58 (40.8)
 Continuous cycling (%) 5 (3.0) 2 (1.4)
 Rapid cycling (%) 4 (2.4) 0 (0.0)
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analysis findings. Bellivier et al. (2014) found significant 
differences in the theoretical AAO functions between 
USA and European BD samples, mainly led by the higher 
proportion of patients in the EO subgroup and the lower 
mean AAO in the USA sample. Finally, birth cohort effect 
might also influence the estimation of AAO subgroups 
parameters. In this regard, Golmard et  al. (2015) found 
that the proportion of EO cases increased substantially 
among BD cases born after 1960 compared to those born 
before the same year.
Several other findings deserve a comment. In our 
sample, BD type 1 patients had an earlier mean AAO 
(26.7 years) than BD2 patients (30.6 years), in agreement 
with existing data showing that BD1 first manifest their 
symptoms at an earlier age (Merikangas et  al. 2011). In 
keeping, admixture analyses indicated a larger propor-
tion of EO cases among BD1 patients (67%) compared 
to BD2 patients (44%). As a consequence, the EO BD1 
group had a later mean AAO (22.6  years), compared to 
EO BD2 patients (20.9 years), reflecting in a higher AAO 
cut-off point (32 years for BD1 and 28 years for BD2).
These distributional properties of AAO distinguishing 
EO BD1 from EO BD2 resulted also in diverse patterns 
of clinical correlates of EO. Indeed, EO BD2 patients 
had a higher rate of alcohol dependence compared to 
both LO BD2 and EO BD1. Similarly, previous stud-
ies investigating clinical correlates of AAO subgroups 
found that EO BD patients have higher rates of alcohol 
abuse (Javaid et al. 2011; Lin et al. 2006). However, these 
studies either analysed only BD1 individuals (Lin et al. 
2006) or did not specify the diagnostic stratification 
(Javaid et  al. 2011). Interestingly, a recent study from 
Propper et al. (2015) did not find differences in rates of 
alcohol abuse among AAO subgroups in a sample with a 
BD1:BD2 ratio of 2:1.
Early onset BD2 patients had more frequently a DMI 
type of clinical course, while the MDI type was more fre-
quently associated with EO BD1. Although not directly 
comparable with our study, the findings reported by Per-
lis et al. (2004) and Propper et al. (2015) in their samples 
relatively balanced in terms of BD1:BD2 ratio, indicated 
that very EO and EO BD patients have more frequently 
onset episodes of depressive polarity compared to later 
onset subgroups. In addition, our findings were consist-
ent with the work of Koukopoulos et  al. (2013), which 
found that patients with a DMI illness course are more 
likely to be BD2, while MDI illness course is overrepre-
sented in BD1 patients.
Differently from what reported in the literature, our 
study failed to confirm in the BD1 subgroup the well-
established association of EO BD with a higher familial 
load for BD and for mood disorders in general, as well as 
with higher rates of suicidal behaviour (Geoffroy et  al. 
2013). On the contrary, EO BD2 showed a higher famil-
ial load for BD (p =  0.02) compared to LO BD. Finally, 
although not statistically significant, EO BD2 showed 
higher rates of family history for BD as well as for mood 
disorders, compared to EO BD1. Similarly, Baek et  al. 
(2011) found higher rates of major depression, but not 
of BD, in BD2 patients compared to BD1, although their 
sample was not stratified according to AAO. Further, 
another recent study showed that both BD1 and BD2 
presented a similar familial load for mood disorders 
(Dell’Osso et al. 2016)
There is compelling evidence that EO BD patients 
appear also to be more frequently associated with rapid 
cycling, drug abuse, higher rates of obsessive–compulsive 
disorder, and possibly for psychotic features, and panic 
disorder (Geoffroy et  al. 2013). Although our study did 
not test for association most of these clinical correlates, 
there were no statistically significant associations with 
EO for drug dependence. Of note, most of this evidence 
is derived from BD1 samples as there is a lack of data 
on the analysis of AAO in BD2, while only a few stud-
ies investigated mixed samples with both BD1 and BD2 
patients (Perlis et  al. 2004; Severino et  al. 2009; Tozzi 
et al. 2011; Ortiz et al. 2011; Propper et al. 2015).
Our results should be interpreted in the context of 
some limitations. The retrospective assessment of AAO 
might have been subject to recall bias. However, data 
were gathered through direct interview of the patients as 
well as with systematic review of medical charts decreas-
ing the probability of a systematic bias in the assessment 
of AAO. An additional limitation is the lack of a system-
atic approach in collecting family history data, which 
might have influenced the assessment of familial load in 
our sample. Moreover, external corroboration for AAO 
was obtained, whenever possible, by directly interviewing 
a first-degree family member or other significant individ-
uals. Further, our samples of BD1 and BD2 patients might 
not have had an adequate statistical power to detect asso-
ciation signals of small to moderate magnitude. Finally, 
our study did not consider birth cohort effect in our 
analysis.
Conclusions
To our knowledge, this is the first study specifically aimed 
at comparing clinical correlates of EO between BD1 and 
BD2 patients’ populations using admixture analysis. Our 
work found that, beside diverse distributional proper-
ties of AAO, BD1 and BD2 EO subgroups differed also in 
their clinical characteristics. Of note, our study identified 
a subgroup of EO BD2 with an AAO even earlier than in 
the EO BD1 subgroup, characterised by a higher genetic 
load (i.e. higher familial load for BD) and at greater risk 
of developing alcohol dependence. Should our findings 
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be replicated in other studies directly comparing AAO 
BD1 subgroups with AAO BD2 subgroups, future work 
will be able to focus also on the differences in the genetic 
and biological makeup, possibly facilitating the search for 
reliable disease biomarkers.
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